[1] 吴佳林,张若兰,刘燕群,等.Hsa_circ_0140180通过调控miR-1287-5p影响食管鳞状细胞癌细胞的迁移及侵袭能力[J].中国肿瘤生物治疗杂志, 2023, 30:114-122. [2] 陈君,李林艳,赵晓勇,等.罗哌卡因通过AKT/GSK-3β/β-catenin信号通路对膀胱癌细胞生长和化疗效果影响[J].中华肿瘤防治杂志, 2023:1208-1222. [3] Chang Y, Jia HQ, Xu B, et al. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway[J]. Chem Biol Drug Des, 2024,103:14416. doi: 10.1111/cbdd.14416. [4] Jin M, Yuan T, Tian K, et al. Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p/profilin 2 axis[J]. Cell Mol Biol Lett, 2024,29:43. doi: 10.1186/s11658-024-00549-x. [5] Xiao Y, Gu S, Yao W, et al. Circ_0047921 acts as the sponge of miR-1287-5p to stimulate lung cancer progression by regulating proliferation, migration, invasion, and glycolysis of lung cancer cells[J]. World J Surg Oncol, 2022,20:108. doi:10.1186/s12957-021-02466-1. [6] Han Q, Ma L, Shao L, et al. Circ_0075804 regulates the expression of LASP1 by targeting miR-1287-5p and thus affects the biological process of retinoblastoma[J]. Curr Eye Res, 2022, 47:1077-1086.doi: 10.1080/02713683.2022.2053164. [7] Guo W, Wu Z, Chen J, et al. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immun-otherapy by promoting ferroptosis[J]. J Immunother Cancer, 2022, 10:e004381. doi: 10.1136/jitc-2021-004381. [8] 赵磊,王一斐,薛国勇.lncRNA BLACAT1通过靶向miR-374b-5p对卵巢癌细胞紫杉醇耐药性的影响及其机制[J].中国老年学杂志, 2022, 42:5616-5621. [9] 史铁伟,李天柱,周静,等.5-脂氧合酶激活蛋白抑制剂MK886对人食管癌细胞系增殖和凋亡的影响[J].基础医学与临床,2022,42:56-61. [10] 张洋,赵辰戈,程荔春,等.miR-152-3p表达下调降低紫杉醇耐药人卵巢癌细胞A2780T对紫杉醇的耐药性[J].中国药理学与毒理学杂志, 2024, 38:22-30. [11] Hu W, Shen J, Tao Y, et al. CCDC85C suppresses colorectal cancer cells proliferation and metastasis through activating GSK-3β and promoting β-catenin degradation[J]. Cell Signal, 2023,109:110799. doi: 10.1016/j.cellsig.2023.110799. [12] Wang N, Hou SY, Qi X, et al. LncRNA LPAL2/miR-1287-5p/EGFR axis modulates TED-derived orbital fibroblast activation through cell adhesion factors[J]. J Clin Endocrinol Metab, 2021,106:2866-2886. doi: 10.1210/clinem/dgab256. |